Skip to content

Screening for Heart Failure Using a Multimodal Wearable Device

Heart Failure

The purpose of this study is to find out if there are any patterns in the way people's bodies react to physical activities and their voices when they have heart failure, a disease where the heart cannot function sufficiently. To do this, the investigators will use a smartwatch that can measure multiple signals like the participant's heart rate and movement. Investigators will ask participants with and without heart failure to wear the Watch HOP (from HOP-Child Technologies Inc.) and sensors during physical tasks at their clinic visit at the McGill University Health Centre. Researchers will also record the participants' voices between their visits. The key signals can help find who is at risk for heart failure or develop new ways to monitor and treat it.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

1. Able to follow up with the study protocol schedule
2. Life expectancy \> 1 year
3. Case group only

1. Clinical signs and/or symptoms of heart failure caused by a structural and/or functional cardiac abnormality, as defined by Bozkurt et al. \[2021\], diagnosed at the cardiovascular clinic
2. NT-proBNP levels \> 125 pg/L or objective evidence of cardiogenic pulmonary or systemic congestion
3. One of the following;

i. For HFpEF, LVEF ≥ 50% ii. For HFmrEF, LVEF 41-49% iii. For HFrEF, LVEF ≤ 40%
4. Control group only

1. Absence of known clinical heart failure history.
2. Absence of criteria above in the case group.

Exclusion Criteria:

1. Any person who does not meet the above criteria or who refuses to participate
2. Undergoing chemotherapy or dialysis
3. In addition, the following list of criteria are specific to accurate wrist wearable measurements:

1. Skin burns or rashes on the measurement locations (wrist for wearable, finger for oximeter, chest for Polar ECG)
2. Patients with tremors
3. Recent use of dermatological creams, ointments, or lotions at the recording area

Study Location

McGill University Health Centre
McGill University Health Centre
Montreal, Quebec
Canada

Contact Study Team

Primary Contact

Abhinav Sharma, MD

[email protected]
514 934-1934
Study Sponsored By
McGill University Health Centre/Research Institute of the McGill University Health Centre
Participants Required
More Information
Study ID: NCT06335264